Hepcidin for clinicians

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 8, 2009, Pages 1384-1387

  Young, Brian ^a   Zaritsky, Joshua ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; FERROPORTIN; HEPCIDIN; IRON; RECOMBINANT ERYTHROPOIETIN; ANTIMICROBIAL CATIONIC PEPTIDE; BIOLOGICAL MARKER;

ANEMIA; CHRONIC KIDNEY DISEASE; HUMAN; INFLAMMATION; INTESTINE ABSORPTION; IRON ABSORPTION; IRON BALANCE; IRON DEFICIENCY; IRON STORAGE; KIDNEY FAILURE; LIVER CELL; MACROPHAGE; NONHUMAN; PROTEIN METABOLISM; SHORT SURVEY; THERAPY RESISTANCE; ANIMAL; BLOOD; CHRONIC DISEASE; DRUG ANTAGONISM; DRUG RESISTANCE; IRON DEFICIENCY ANEMIA; KIDNEY DISEASE; PREDICTION AND FORECASTING; REVIEW; TREATMENT FAILURE;

ANEMIA, IRON-DEFICIENCY; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BIOLOGICAL MARKERS; CHRONIC DISEASE; DRUG RESISTANCE; HEMATINICS; HUMANS; IRON; KIDNEY DISEASES; PREDICTIVE VALUE OF TESTS; TREATMENT FAILURE;

EID: 70349909736     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02190309     Document Type: Short Survey

References (35)

1. Coyne DW, Kapoian T, Suki W, Singh AK, Moran JE, Dahl NV, Rizkala AR: Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: Results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study. J Am Soc Nephrol 18: 975-984, 2007
2. Singh AK, Coyne DW, Shapiro W, Rizkala AR: Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation. Kidney Int 71: 1163-1171, 2007
3. Park CH, Valore EV, Waring AJ, Ganz T: Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276: 7806-7810, 2001
4. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loreal O: A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276: 7811-7819, 2001
5. Hunter HN, Fulton DB, Ganz T, Vogel HJ: The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem 277: 37597-37603, 2002
6. Viatte L, Lesbordes-Brion JC, Lou DQ, Bennoun M, Nicolas G, Kahn A, Canonne-Hergaux F, Vaulont S: Deregulation of proteins involved in iron metabolism in hepcidin-deficient mice. Blood 105: 4861-4864, 2005
7. Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, Sirito M, Sawadogo M, Kahn A, Vaulont S: Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A 99: 4596-4601, 2002
8. Papanikolaou G, Tzilianos M, Christakis JI, Bogdanos D, Tsimirika K, MacFarlane J, Goldberg YP, Sakellaropoulos N, Ganz T, Nemeth E: Hepcidin in iron overload disorders. Blood 105: 4103-4105, 2005
9. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J: Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306: 2090-2093, 2004
10. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T: IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113: 1271-1276, 2004
11. Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, Samad TA, Campagna JA, Chung RT, Schneyer AL, Woolf CJ, Andrews NC, Lin HY: Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 38: 531-539, 2006
12. Lin L, Valore EV, Nemeth E, Goodnough JB, Gabayan V, Ganz T: Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. Blood 110: 2182-2189, 2007
13. Babitt JL, Huang FW, Xia Y, Sidis Y, Andrews NC, Lin HY: Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J Clin Invest 117: 1933-1939, 2007
14. Schmidt PJ, Toran PT, Giannetti AM, Bjorkman PJ, Andrews NC: The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metab 7: 205-214, 2008
15. Goswami T, Andrews NC: Hereditary hemochromatosis protein HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J Biol Chem 281: 28494-28498, 2006
16. Vokurka M, Krijt J, Sulc K, Necas E: Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. Physiol Res 55: 667-674, 2006
17. Pak M, Lopez MA, Gabayan V, Ganz T, Rivera S: Suppression of hepcidin during anemia requires erythropoietic activity. Blood 108: 3730-3735, 2006
18. Kearney SL, Nemeth E, Neufeld EJ, Thapa D, Ganz T, Weinstein DA, Cunningham MJ: Urinary hepcidin in congenital chronic anemias. Pediatr Blood Cancer 48: 57-63, 2007
19. Tanno T, Bhanu NV, Oneal PA, Goh SH, Staker P, Lee YT, Moroney JW, Reed CH, Luban NL, Wang RH, Eling TE, Childs R, Ganz T, Leitman SF, Fucharoen S, Miller JL: High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 13: 1096-1101, 2007
20. Swinkels DW, Girelli D, Laarakkers C, Kroot J, Campostrini N, Kemna EH, Tjalsma H: Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. PLoS ONE 3: e2706, 2008
21. Detivaud L, Nemeth E, Boudjema K, Turlin B, Troadec MB, Leroyer P, Ropert M, Jacquelinet S, Courselaud B, Ganz T, Brissot P, Loreal O: Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function. Blood 106: 746-748, 2005
22. Kulaksiz H, Gehrke SG, Janetzko A, Rost D, Bruckner T, Kallinowski B, Stremmel W: Pro-hepcidin: Expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut 53: 735-743, 2004
23. Taes YE, Wuyts B, Boelaert JR, De Vriese AS, Delanghe JR: Prohepcidin accumulates in renal insufficiency. Clin Chem Lab Med 42: 387-389, 2004
24. Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M: Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis. Am J Hematol 81: 832-837, 2006
25. Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M: Hepcidin, an acute-phase protein and a marker of inflammation in kidney transplant recipients with and without coronary artery disease. Transplant Proc 38: 2895-2898, 2006
26. Malyszko J, Malyszko JS, Hryszko T, Pawlak K, Mysliwiec M: Is hepcidin a link between anemia, inflammation and liver function in hemodialyzed patients? Am J Nephrol 25: 586-590, 2005
27. Kato A, Tsuji T, Luo J, Sakao Y, Yasuda H, Hishida A: Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients. Am J Nephrol 28: 115-121, 2008
28. Hadley KB, Johnson LK, Hunt JR: Iron absorption by healthy women is not associated with either serum or urinary prohepcidin. Am J Clin Nutr 84: 150-155, 2006
29. Roe MA, Spinks C, Heath AL, Harvey LJ, Foxall R, Wimperis J, Wolf C, Fairweather-Tait SJ: Serum prohepcidin concentration: No association with iron absorption in healthy men; and no relationship with iron status in men carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women. Br J Nutr 97: 544-549, 2007
30. Kemna E, Pickkers P, Nemeth E, van der Hoeven H, Swinkels D: Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 106: 1864-1866, 2005
31. Tomosugi N, Kawabata H, Wakatabe R, Higuchi M, Yamaya H, Umehara H, Ishikawa I: Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System. Blood 108: 1381-1387, 2006
32. Li H, Rose MJ, Tran L, Zhang J, Miranda LP, James CA, Sasu BJ: Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LCMS/ MS. J Pharmacol Toxicol Methods 59: 171-180, 2009
33. Zaritsky J, Young B, Wang HJ, Westerman M, Olbina G, Nemeth E, Ganz T, Rivera S, Nissenson AR, Salusky IB: Hepcidin: A potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol 4: 1051-1056, 2009
34. Ashby DR, Gale DP, Busbridge M, Murphy KG, Duncan ND, Cairns TD, Taube DH, Bloom SR, Tam FW, Chapman RS, Maxwell PH, Choi P: Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int 75: 976-981, 2009
35. Kroot J, Kenma EH, Bansal S, Busbridge M, Campostrini N, Girelli D, Hider RC, Koliaraki V, Mamalaki A, Olbina G, Tomosugi N, Tselepis C, Ward DG, Ganz T, Hendriks JC, Swinkels DW: Results of the First International Round Robin for the Quantification of Urinary and Plasma Hepcidin: Need for Standardization. Presented at the 50th annual meeting and exposition of the American Society of Hematology; San Francisco, CA; December 7, 2008